.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cerilliant
QuintilesIMS
Fish and Richardson
Novartis
Moodys
Argus Health
Covington
US Army
Federal Trade Commission

Generated: July 20, 2017

DrugPatentWatch Database Preview

MELFIAT-105 Drug Profile

« Back to Dashboard

What is the patent landscape for Melfiat-105, and when can generic versions of Melfiat-105 launch?

Melfiat-105 is a drug marketed by Numark and is included in one NDA.

The generic ingredient in MELFIAT-105 is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for Tradename: MELFIAT-105

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list9
Clinical Trials: see list232
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MELFIAT-105 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Numark
MELFIAT-105
phendimetrazine tartrate
CAPSULE, EXTENDED RELEASE;ORAL087487-001Oct 13, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Accenture
Covington
Johnson and Johnson
McKesson
Colorcon
Cerilliant
Deloitte
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot